150 related articles for article (PubMed ID: 38610916)
1. Efficacy of Trimetazidine in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Contrast Coronary Intervention: A Systematic Review and Meta-Analysis (PRISMA).
Nair T; Ray S; George J; Pande A
J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610916
[No Abstract] [Full Text] [Related]
2. Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA).
Heshmatzadeh Behzadi A; Amoozgar B; Jain S; Velasco N; Zahid U; Abbasi H; Alasadi L; Prince MR
Medicine (Baltimore); 2021 Mar; 100(10):e24603. PubMed ID: 33725824
[TBL] [Abstract][Full Text] [Related]
3. The effect of trimetazidine on contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention - A systematic review and meta-analysis.
Martha JW; Pranata R; Wibowo A; Irvan I; Afrianti R; Akbar MR
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3045-3053. PubMed ID: 33877668
[TBL] [Abstract][Full Text] [Related]
4. Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis.
Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
Medicine (Baltimore); 2017 Mar; 96(9):e6059. PubMed ID: 28248861
[TBL] [Abstract][Full Text] [Related]
5. The effect of trimetazidine on preventing contrast-induced nephropathy after cardiac catheterization.
Lian X; He W; Zhan H; Chen J; Tan N; He P; Liu Y
Int Urol Nephrol; 2019 Dec; 51(12):2267-2272. PubMed ID: 31641999
[TBL] [Abstract][Full Text] [Related]
6. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency.
Fu H; Zhang J; Zhang H; Zhang P; Fu X; Zeng Z; Zhang X; Li W; Yang S; Liu X; Fu N
Perfusion; 2021 Sep; 36(6):603-609. PubMed ID: 32909511
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.
Chen F; Liu F; Lu J; Yang X; Xiao B; Jin Y; Zhang J
Eur J Med Res; 2018 May; 23(1):23. PubMed ID: 29776437
[TBL] [Abstract][Full Text] [Related]
9. Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.
Nadkarni GN; Konstantinidis I; Patel A; Yacoub R; Kumbala D; Patel RA; Annapureddy N; Pakanati KC; Simoes PK; Javed F; Benjo AM
J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):539-46. PubMed ID: 25715308
[TBL] [Abstract][Full Text] [Related]
10. Preventive effect of trimetazidine on contrast-induced nephropathy undergoing percutaneous coronary intervention in elderly moderate and high risk diabetics stratified by mehran score.
Zhang X; Zhang P; Yang S; Li W; Men X; Fu N
Perfusion; 2021 Jul; 36(5):491-500. PubMed ID: 32838661
[TBL] [Abstract][Full Text] [Related]
11. Trimetazidine Prevention of Contrast-Induced Nephropathy in Coronary Angiography.
Liu W; Ming Q; Shen J; Wei Y; Li W; Chen W; Xu Y
Am J Med Sci; 2015 Nov; 350(5):398-402. PubMed ID: 26445302
[TBL] [Abstract][Full Text] [Related]
12. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
Shehata M
Am J Cardiol; 2014 Aug; 114(3):389-94. PubMed ID: 24927970
[TBL] [Abstract][Full Text] [Related]
13. Trimetazidine in the prevention of contrast induced nephropathy after coronary angiogram.
Rahman MM; Haque SS; Rokeya B; Siddique MA; Banerjee SK; Ahsan SA; Rahman F; Mahmood M; Ahmed K; Bhuiyan MM; Joarder AI; Debnath RC
Mymensingh Med J; 2012 Apr; 21(2):292-9. PubMed ID: 22561774
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of allopurinol in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Mansoor K; Suliman M; Amro M; Malik S; Amro A; Curtis Z; El-Hamdani M; Ogu I; Aronow WS
Arch Med Sci Atheroscler Dis; 2021; 6():e196-e202. PubMed ID: 36161220
[TBL] [Abstract][Full Text] [Related]
15. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.
Onbasili AO; Yeniceriglu Y; Agaoglu P; Karul A; Tekten T; Akar H; Discigil G
Heart; 2007 Jun; 93(6):698-702. PubMed ID: 17065180
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Effectiveness of Pretreatment With Intravenous Fluid in Reducing the Risk of Developing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis.
Zaki HA; Bashir K; Iftikhar H; Alhatemi M; Elmoheen A
Cureus; 2022 May; 14(5):e24825. PubMed ID: 35693368
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency.
Ye Z; Lu H; Su Q; Xian X; Li L
Oncotarget; 2017 Nov; 8(60):102521-102530. PubMed ID: 29254267
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Wang C; Chen W; Yu M; Yang P
Angiology; 2021 Jul; 72(6):511-523. PubMed ID: 33472383
[TBL] [Abstract][Full Text] [Related]
20. Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.
Pranata R; Tondas AE; Vania R; Toruan MPL; Lukito AA; Siswanto BB
Catheter Cardiovasc Interv; 2020 Nov; 96(6):1200-1212. PubMed ID: 31912996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
